Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Newer antidepressants and the cytochrome P450 system.

The American journal of psychiatry - 1 Mar 1996

Nemeroff C B, DeVane C L, Pollock B G

Abstract excerpt

OBJECTIVE: This review evaluates the in vitro and in vivo evidence for inhibition of cytochrome P450 enzymes by the newer antidepressants and provides clinical recommendations for avoiding and managing drug interactions. METHOD: The international literature on the cytochrome P450 system and related drug interactions from 1966 to 1995 was reviewed. In vitro studies, pharmacokinetic trials in human subjects, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Cytochrome P-450 CYP2D6
Share to Depressive Disorder

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Interactions

Share to In Vitro Techniques

Share to Mixed Function Oxygenases

Share to Oxidoreductases

Share to Phenotype

Source

Identifiers

PMID: 8610817
DOI: 10.1176/ajp.153.3.311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Newer antidepressants and the cytochrome P450 system.PMID 8610817Read ↗

Pharmacogenetics and drug metabolism of newer antidepressant agents.Semantic proximity Read ↗

Drug interactions--friend or foe?Semantic proximity Read ↗

The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.Semantic proximity Read ↗

Cytochrome p450 part 3: drug interactions: essential concepts and considerations.Semantic proximity Read ↗

CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.Semantic proximity Read ↗

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort studySemantic proximity Read ↗

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.Semantic proximity Read ↗

Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.Semantic proximity Read ↗

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study.Semantic proximity Read ↗

[The relationship of cytochrome P450 isoforms with the efficacy and safety of antipsychotic and antidepressant therapy].Semantic proximity Read ↗

Antidepressant drugs in the elderly--role of the cytochrome P450 2D6.Semantic proximity Read ↗

Doxepin Drug-Drug and Drug-Gene Interactions: Clinical Implications and Mechanistic InsightsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.